den Uil SH, de Wit M, Slebos RJC, Delis-van Diemen PM, et al. Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. Eur J Cancer 2020;144:91-100.
PMID: 33341450